Literature DB >> 7448940

Synthetic nucleosides and nucleotides. XVI. Synthesis and biological evaluations of a series of 1-beta-D-arabinofuranosylcytosine 5'-alkyl or arylphosphates.

M Saneyoshi, M Morozumi, K Kodama, H Machida, A Kuninaka, H Yoshino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7448940     DOI： 10.1248/cpb.28.2915

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetics of cytarabine formulations.

Authors:  Akinobu Hamada; Takeo Kawaguchi; Masahiro Nakano
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Inhibitory effects of 3'deoxycytidine 5'-triphosphate and 3'-deoxyuridine 5'-triphosphate on DNA-dependent RNA polymerases I and II purified from Dictyostelium discoideum cells.

Authors:  M Saneyoshi; J Tohyama; C Nakayama; S Takiya; M Iwabuchi
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

3.  Evolution of an amino acid based prodrug approach: stay tuned.

Authors:  Ivan S Krylov; Boris A Kashemirov; John M Hilfinger; Charles E McKenna
Journal:  Mol Pharm       Date:  2013-01-22       Impact factor: 4.939

4.  Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.

Authors:  M Higashigawa; H Hori; T Ohkubo; H Kawasaki; T Yoshizumi; M Sakurai
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

5.  Combined oral administration of etoposide and arabinofuranosylcytosine-5'-stearylphosphate enhances the antitumor effect against P388 ascites tumors.

Authors:  M Higashigawa; D C Cao; K Matsui; S Yamada; H Kakitou; Y Kagawa; H Inamochi; M Ido; M Sakurai
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 6.  Improving nucleoside analogs via lipid conjugation: Is fatter any better?

Authors:  Peter Alexander; Gregory Kucera; Timothy S Pardee
Journal:  Crit Rev Oncol Hematol       Date:  2016-01-21       Impact factor: 6.312

7.  Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.

Authors:  K Kodama; M Morozumi; K Saitoh; A Kuninaka; H Yoshino; M Saneyoshi
Journal:  Jpn J Cancer Res       Date:  1989-07

8.  New prodrugs of Adefovir and Cidofovir.

Authors:  Tomáš Tichý; Graciela Andrei; Martin Dračínský; Antonín Holý; Jan Balzarini; Robert Snoeck; Marcela Krečmerová
Journal:  Bioorg Med Chem       Date:  2011-04-22       Impact factor: 3.641
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.